Unmatched performance and flexibility in its class

The new ZEISS SPECTRUM family is equipped to be the ideal match from measuring small electronics up to larger housings.

Standardisation in automation

B. Braun Melsungen had a great idea and implemented it throughout the plant. Production for infusion solutions was to be largely standardised. B. Braun hoped th...

AstraZeneca to use American AI platform for cancer trials

In a collaboration AstraZeneca will use an AI model from Israeli-American biotech Immunai to streamline its clinical trials in cancer.

Galderma

Här är artiklarna som lästes mest i september

En svensk toppforskare som värvas av en läkemedelsjätte och en biotech-vd som lämnar efter en tuff tid bakom sig. Det hör till nyheterna som har lästs mest i september.

Festo Expands its Portfolio with Multilayer Manifolds

Manufacturers of medical and laboratory equipment now receive solutions from a single source

Basics of Confocal Laser Scanning Microscopy

Learn about the principle of confocal fluorescence microscopy.

Umeåbolag ska utveckla test för bloddopning

Umeåbolaget Protest Diagnostics har fått 1,2 miljoner kronor av den internationella antidopningsbyrån Wada för att utveckla ett test som ska upptäcka bloddopning.

Stockholm and Uppsala jointly form a life science cluster

Stockholm and Uppsala are strengthening cooperation in medical research and biotech.

Webinar: Automate your processes

Free ZEISS webinar on January 30th, 2025.

Johan Pehrson takes over the responsibility for research policy in Sweden

The Liberals' party leader Johan Pehrson takes over the assignment as Minister for Education. This was announced by Prime Minister Ulf Kristersson (M) on Tuesday last week.

Ny motgång för Pfizers satsning inom obesitas

Pfizers ambitioner inom obesitas har fått sig en ny törn. Nu lägger bolaget ner ännu ett GLP-1-projekt.

Italian pharmaceutical company buys rights to immunotherapy from Sanofi

Italy's Recordati buys the rights to a treatment for the rare autoimmune disease cold agglutinin disease (CAD).

To build trust, one must be able to say “I don’t know” – whether human or AI

Will AI strengthen or break down trust? It depends on whether we can understand and accept its limitations, and our own, writes Sarah Lidé in a column.

Snabbtest för halsfluss gav 40 procent falskt positiva svar

Ett snabbtest mot halsfluss har visat sig ge en mycket hög andel falskt positiva svar. Nu uppmanar företaget bakom testet vårdgivare att kassera berörda partier av produkten.

Improve Productivity and Accessibility with Award-winning Human-Centered Design

Enhance your workflow with integrated intelligence.

Takeover bid is being completed – Japanese company acquires Calliditas

Japanese company Asahi Kasei completes the bid for Calliditas Therapeutics after reaching over 90 percent of the shareholding. Callidita's board has now decided...

Quality solutions for medical device R&D applications

From R&D to the quality assurance of series production in medical device manufacturing.

Mavatar AB

SupraCube - In life Science

Superconductors must be permanently kept below their transition temperature for levitation. Because of the integrated cooler, applications with superconductors ...

Galenica AB

Pneumatics Makes a Technological Leap with Piezo

The first high-precision proportional valve terminal VTEP opens up new application areas

What will be the next big hype after obesity? – An expert panel highlighted their top picks

What will be the next big trend in life science? Everything from Alzheimer’s, Crispr and Omics were highlighted when the issue was debated at this year’s major ...

Två patienter dog – läkemedelsprogram läggs ned

Det amerikanska biotechbolaget Schrödinger avbryter utvecklingen av ett leukemiläkemedel sedan två patienter avlidit i en klinisk studie i tidig fas.